-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 59.2% to $1.99 during Wednesday's pre-market session.
  • Lipocine (NASDAQ:LPCN) shares rose 52.38% to $3.2. The company's market cap stands at $17.3 million.
  • Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 15.66% to $0.8. The market value of their outstanding shares is at $12.7 million.
  • Lakewood-Amedex (NASDAQ:LABT) stock moved upwards by 15.34% to $1.0. The company's market cap stands at $2.0 million.
  • Neogen (NASDAQ:NEOG) shares moved upwards by 14.18% to $13.66. The market value of their outstanding shares is at $2.6 billion. The company's, Q1 earnings came out yesterday.
  • Treace Medical Concepts (NASDAQ:TMCI) shares moved upwards by 9.74% to $4.39. The company's market cap stands at $260.1 million.

Losers

  • Caribou Biosciences (NASDAQ:CRBU) shares decreased by 44.2% to $0.63 during Wednesday's pre-market session. The company's market cap stands at $121.6 million.
  • Actuate Therapeutics (NASDAQ:ACTU) stock fell 22.11% to $0.63. The market value of their outstanding shares is at $19.4 million.
  • QTREX Quantum (NASDAQ:QTEX) shares decreased by 11.38% to $1.41. The company's market cap stands at $106.6 million.
  • Jupiter Neurosciences (NASDAQ:JUNS) shares decreased by 8.4% to $2.62. The market value of their outstanding shares is at $3.7 million.
  • Kairos Pharma (AMEX:KAPA) shares fell 7.83% to $1.06. The company's market cap stands at $3.8 million.
  • NexGel (NASDAQ:NXGL) shares fell 7.29% to $0.16. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending